Results 91 to 100 of about 16,753 (223)

Helping Smokers Quit: State Cessation Coverage [PDF]

, 2008
Analyzes state health insurance coverage for treatments to quit smoking and how coverage through state Medicaid, state employee health plans, private insurance, and "quitlines" saves states healthcare costs.

core  

Varenicline for smoking cessation: efficacy, safety, and treatment recommendations

Patient Preference and Adherence, 2010
Jon O Ebbert, Kirk D Wyatt, J Taylor Hays, Eric W Klee, Richard D HurtMayo Clinic College of Medicine, Rochester, MN, USAAbstract: Smoking is the leading preventable cause of morbidity and mortality in the US, and decreasing smoking prevalence is a ...
Jon O Ebbert, Kirk D Wyatt, J Taylor Hays, et al   +3 more
doaj  

The data set describing cognitive performance after varenicline administration in a 3-choice serial reaction time task in rats

Data in Brief, 2017
The data shows attentional function, impulsivity, motivation, motor function, and motor activity in rats treated with varenicline, a stop-smoking aid.
Yu Ohmura, Hitomi Sasamori, Iku Tsutsui-Kimura, Takeshi Izumi, Takayuki Yoshida, Mitsuhiro Yoshioka   +5 more
doaj   +1 more source

Changes in body weight and food choice in those attempting smoking cessation: a cluster randomised controlled trial [PDF]

, 2012
<p><b>Background:</b> Fear of weight gain is a barrier to smoking cessation and significant cause of relapse for many people. The provision of nutritional advice as part of a smoking cessation programme may assist some in smoking ...
AAWA van der Heijen, AC Parsons, Andrew Walker, AR Dyer, C Filozoff, Catherine R Hankey, F Pistelli, G Colletti, Heather M Murray, J Armstrong, J Stevens, JE Audrain, JE Cade, L Bauld, LR Purslow, MD Levine, MEJ Lean, MG Perri, Mhairi Mackenzie, Michael EJ Lean, P Hajek, Preethi R Koshy, R Ara, RC Klesges, S Chinn, S Rossner, St Stewart, Susan Boyle, Wilma S Leslie   +28 more
core   +3 more sources

2532

Journal of Clinical and Translational Science, 2017
OBJECTIVES/SPECIFIC AIMS: The central goal is to predict the metabolites of varenicline and predictively evaluate their propensities for eliciting an increased binding effect in the brain.
Keeshaloy Thompson, Milton Brown
doaj   +1 more source

A randomized trial of varenicline (Chantix) for the treatment of spinocerebellar ataxia type 3. [PDF]

, 2012
n/
DE MICHELE, GIUSEPPE, FILLA, ALESSANDRO, SACCA', FRANCESCO   +2 more
core   +1 more source

Differentiating the primary reinforcing and reinforcement-enhancing effects of varenicline in a 2-lever, rat self-administration paradigm [PDF]

, 2013
Nicotine (NIC) has two reinforcement-related effects that may contribute to dependence: 1) NIC acts as a primary reinforcer, and 2) NIC, non-associatively, enhances reinforcement from concur- rently available nonpharmacological stimuli. Varenicline (VAR),
Levin, Melissa
core  

Impact of Continuing Education on Clinicians' Self- Reported Knowledge of Tobacco Dependence and Tobacco Control Interventions [PDF]

, 2018
Purpose: To assess a tobacco cessation continuing education (CE) program for Indiana dental and medical providers. Methods: A 26-item immediate post-CE survey and a 19-item 3-month follow-up survey assessed changes in participants’ self-reported ...
Coan, Lorinda, Romito, Laura M.
core  

Drug-induced liver injury due to varenicline: a case report

BMC Gastroenterology, 2012
Background Liver injury due to prescription and nonprescription medications is an expanding public health concern in the United States, with drug-induced liver injury (DILI) being the single most common reason for regulatory actions instituted by the ...
Sprague David, Bambha Kiran
doaj   +1 more source

Effect of Extending the Duration of Prequit Treatment With Varenicline on Smoking Abstinence [PDF]

, 2022
Larry W. Hawk, Stephen T. Tiffany, Craig R. Colder, Rebecca L. Ashare, Jennifer M. Wray, Rachel F. Tyndale, Thomas H. Brandon, Martin C. Mahoney   +7 more
openalex   +1 more source